Author name: Leonardo Arias

AI is changing the nature of leadership in biopharma. Here’s how executives can not only adapt, but lead the way.

The American Hospital Association warned future tariffs arising from the Trump administration’s Section 232 investigation could disrupt access to an array of tools and personal protective equipment.

Seven Novo Nordisk board members have resigned. The new board headed by former Novo Nordisk CEO Lars Rebien Sørensen will align behind the new CEO’s massive restructuring plan.

Los adelantos tecnológicos están revolucionando el sector.   La industria del casino está avanzando a pasos agigantados gracias al aprovechamiento de los avances en materia de seguridad o de reconocimiento facial. Todo ello ha supuesto que los usuarios se beneficien de …

The partnership with Noom aims to cut costs by treating weight management as preventative healthcare. Nearly 2 million Highmark Health members are expected to be eligible for the programs.

The company is dropping its social anxiety disorder program but will still test the molecule in post-traumatic stress disorder.

The public-private partnership aims to pump money into medical research as federal funds dry up. “We’re facing headwinds galore,” said Advocate’s chief innovation officer.

The tool, which aims to help patients enroll in and maintain coverage, comes as healthcare braces for major cuts to the safety-net insurance program.

Funds managed by Blackstone and TPG plan to acquire the medtech firm for up to $79 per share.

In this episode presented by Element Materials Technology, guests Dr. Jihye Jang-Lee and Dr. Khanh Courtney will explore how healthcare and pharmaceutical players are rethinking their strategies amid global supply chain disruption.